In a recent post at the Wall Street Journal Health Blog, they take a look at how most late stage human clinical trials are done outside of the United States. One reason includes the ability to better monitor the ethical treatment of patients.
According to the article:
Currently, each site in the U.S. must separately approve a study, even if it’s part of a larger trial taking place with an identical protocol at other institutions across the country or world. The National Cancer Institute has started a review process for studies it funds in an attempt to minimize the time it takes for institutions to approve and start studies.
What do you see as driving clinical trials outside of the United States?
Tuesday, February 24, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment